Prestige Consumer Healthcare Inc. (NYSE:PBH) Q2 2023 Earnings Conference Call November 3, 2022 8:30 AM ET
Company Participants
Phil Terpolilli - Vice President, Investor Relations and Treasurer
Ron Lombardi - President and Chief Executive Officer
Christine Sacco - Chief Financial Officer
Conference Call Participants
Rupesh Parikh - Oppenheimer & Co.
Jon Andersen - William Blair
Operator
Good day and thank you for standing by. Welcome to the Prestige Consumer Healthcare Second Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that this call is being recorded.
I will now turn it over to Phil Terpolilli, Vice President of Investor Relations and Treasury. Please go ahead.
Phil Terpolilli
Thanks operator, and thank you to everyone who's joined today. On the call with me are Ron Lombardi, our Chairman, President and CEO; and Christine Sacco, our CFO.
On today's call, we'll review the second quarter fiscal 2023 results, discuss the full year outlook and then take questions from analysts. The slide presentation accompanying today's call can be accessed by visiting prestigeconsumerhealthcare.com, clicking on the Investors link and then on today's webcast and presentation.
Remember, some of the information contained in the presentation today includes non-GAAP financial measures. Reconciliations to the nearest GAAP financial measures are included in the earnings release and slide presentation.
On today's call, management will make forward-looking statements around risks and uncertainties, which are detailed in a complete safe harbor disclosure on page two of the slide presentation, which accompanies the call. These are important to review and contemplate. Business environment uncertainty remains high due to COVID-19, supply chain constraints, high inflation and various geopolitical factors, which have numerous potential impacts. This means results could change at any time from the forecasted impact of reconsiderations of the best estimates based on the information available as of today's date. Further information concerning risk factors and cautionary statements are available on our most recent SEC filings and the most recent company 10-K.
I'll now hand it over to our CEO, Ron Lombardi. Ron?
Ron Lombardi
Thanks Phil. Let's begin on slide five. We are encouraged by our second quarter results, which continued Q1's solid start to fiscal 2023 that we discussed back in August. Revenues of $289 million in Q2 grew over 5% organically versus the prior year.
Our leading portfolio of consumer health care brands remains well-positioned as consumers continue to seek out their trusted brands in today's dynamic environment. This trend underpinned our ongoing brand-building, which generated Q2's record revenue performance and was the highest in company history for the second quarter in a row.